Genex Pharmaceutical
(OTC) GENX
Genex Pharmaceutical Financials at a Glance
Market Cap
$3,600
Revenue (TTM)
$3.24M
Net Income (TTM)
$342.55K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-11.42 (Low)
Dividend
$0.00
Beta (Volatility)
-11.42 (Low)
Price
$0.00
Volume
5,000
Open
$0.00
Price
$0.00
Volume
5,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-11.42 (Low)
Price
$0.00
Volume
5,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
GENX News
GENX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genex Pharmaceutical
GENX Financials
Key Financial Metrics (TTM)
Gross Margin
89%
Operating Margin
14%
Net Income Margin
11%
Return on Equity
0%
Return on Capital
9%
Return on Assets
4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.60K
Shares Outstanding
17.85M
Volume
5.00K
Short Interest
0.00%
Avg. Volume
98.361
Financials (TTM)
Gross Profit
$2.87M
Operating Income
$466.14K
EBITDA
$789.72K
Operating Cash Flow
$529.66K
Capital Expenditure
$1.25K
Free Cash Flow
$528.40K
Cash & ST Invst.
$430.12K
Total Debt
$0.00
Genex Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$894.79K
+31.8%
Gross Profit
$809.19K
+25.5%
Gross Margin
90.43%
N/A
Market Cap
$3.60K
N/A
Market Cap/Employee
$41.86
N/A
Employees
86
N/A
Net Income
$72.59K
-148.7%
EBITDA
$131.81K
+122.2%
Quarterly Fundamentals
Net Cash
$430.12K
+123.8%
Accounts Receivable
$163.82K
-5.3%
Inventory
$484.84K
+5.3%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
3.96%
N/A
Return on Invested Capital
9.01%
N/A
Free Cash Flow
$4.16K
-96.9%
Operating Cash Flow
$5.41K
-96.0%